




Crizotinib Powder Cas 877399-52-5 Boiling Point: 599.177a C At 760 Mmhg
Price Trend: 10.00 - 20.00 USD ($)
Get Latest Price
Minimum Order Quantity :
1g
Product Specifications
Chemical Name | 3-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine |
Usage | Crizotinib is an active pharmaceutical ingredient used for antineoplastics. |
Shelf Life | 2 Years |
CAS No | 877399-52-5 |
Heavy Metal (%) | a 10PPM |
EINECS No | 638-814-9 |
Appearance | white powder |
Type | Pharmaceutical Intermediates |
Smell | No Smell |
Boiling point | 599.177A C at 760 mmHg |
Storage | Room Temperature |
Loss on Drying | a 0.2% |
Taste | Odorless |
Medicine Name | Crizotinib |
Grade | Medicine Grade |
HS Code | 29339900 |
Color | white |
Physical Form | Powder |
Purity(%) | 99 |
Molecular Formula | C21H22Cl2FN5O |
Structural Formula | C21H22Cl2FN5O |
Molecular Weight | 450.343 Pound (lb) |
Melting Point | 599.177A C at 760 mmHg |
Certifications | ISO9001 |
Supply Ability | 500 Per Month |
Sample Policy | Within a certain price range free samples are available |
Packaging Details | as per request |
Main Export Market(s) | South America |
Main Export Market(s) | Central America |
Main Export Market(s) | Africa |
Main Export Market(s) | Western Europe |
Main Export Market(s) | North America |
Main Export Market(s) | Asia |
Main Domestic Market | All India |
FOB Port | any port in China |
Delivery Time | 1 Week |
Payment Terms | Cash in Advance (CID) |
Payment Terms | Cash Against Delivery (CAD) |
Payment Terms | Paypal |
Payment Terms | Letter of Credit at Sight (Sight L/C) |
Payment Terms | Days after Acceptance (DA) |
GSTIN | 0% |
Company Details
Business Type
Exporter, Manufacturer, Supplier
Employee Count
25
Establishment
2014
Working Days
Monday To Sunday
Related Products
Explore Related Categories
Seller Details
Shijiazhuang, Hebei
General Manager
Ms. Lily
Address
B No.52 Zhaiying South street,Yuhua Dostrict, Shijiazhuang, Hebei, 050000, China
active pharmaceutical ingredients in Shijiazhuang
Report incorrect details